Status:

TERMINATED

Cubicin(R) for Complicated Post-surgical Wound Infections

Lead Sponsor:

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Conditions:

Wound Infections

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of the study is to describe the clinical efficacy of CUBICIN therapy in patients with superficial and deep post-surgical Gram-positive wound infections

Detailed Description

A multi-center, single-arm, open-label, non-comparative study to describe the clinical efficacy of CUBICIN therapy in patients with superficial and deep post-surgical Gram-positive wound infections. A...

Eligibility Criteria

Inclusion

  • Read and signed informed consent form
  • female of childbearing potential, negative pregnancy test result
  • Confirmed diagnosis of post-surgical wound infections known or suspected (based on Gram stain) to be due to Gram-positive organisms obtained within 3 calendar days prior to first dose of study medication
  • Onset of surgical wound infection within 30 days after surgery
  • At least three clinical signs and symptoms of skin infection

Exclusion

  • previous systemic antimicrobial therapy exceeding 24 hours duration administered anytime during 72 hours prior to the first dose of study drug
  • Uncomplicated surgical infections (eg, stitch abscesses)
  • osteomyelitis, pneumonia, bacteremia, endocarditis, or urinary tract infection
  • Any type of space infection
  • Conditions requiring surgical removal of wound infection
  • necrotizing fasciitis, synergistic gangrene, Clostridial myonecrosis (gas gangrene), or Fournier's gangrene;
  • Foreign material involved in the post-surgical wound infection
  • Known to be allergic or intolerant to study medication
  • Creatinine Clearance (CLCR) \<30 mL/min
  • history of neurological disease (eg, Guillain-Barré, multiple sclerosis)

Key Trial Info

Start Date :

June 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2005

Estimated Enrollment :

69 Patients enrolled

Trial Details

Trial ID

NCT00651131

Start Date

June 1 2004

End Date

March 1 2005

Last Update

August 30 2017

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Cubicin(R) for Complicated Post-surgical Wound Infections | DecenTrialz